NOW AVAILABLE IN THE UNITED STATES, Medinol's fifth generation coronary stent, the NIRxcell, is made from cobalt-chromium alloy using our QualitySurface manufacturing technology. The Flexx² catheter technology provides NIRxcell an unmatched ease-of-delivery, especially in tough anatomies. Featuring the unique WiZeCell stent design, that ensures optimal balance between conformability and scaffolding, NIRxcell showed outstanding results in recent clinical studies.
Medinol is dedicated to the science of cardiovascular intervention. For over 20 years, our in-house research, d
Medinol’s Flexx² catheter technology is a game-changer in coronary stent deliverability, especially in tough anatomies. Flexx² raises delivery efficiency and visibility, while lowering overall procedure time.
Now in its fifth generation, the innovative WiZeCell Design continues to lead modern stenting, eliminating any compromise between vessel conformability, scaffolding integrity, and radial support.
All Medinol cardiovascular intervention solutions are manufactured in our proprietary manufacturing facility. Leveraging the unique and patented QualitySurface™ manufacturing technology, Medinol conducts strict and automated quality control on each individual stent, ensuring consistently exceptional product quality and safety.
Medinol’s patented eDES technology* (eDES: elastomeric Drug-Eluting Stent) changes the face of drug-eluting stenting by lowering the risks associated with surface imperfections and deformations that can lead to polymer cracking and peeling.
*Currently in clinical studies
© 2014 Medinol Ltd · MKW2001-0
The website you have requested may contain information on products or uses of such products that are not approved in your country. For specific product and country information please contact MedinolContinue